ArticleCell & bioscience2023

Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel.

Jingyao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.